Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hunt SA, Baker DW, Chin MH, Cinquegrani MP, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Am Coll Cardiol 2001;38:2101–2113.
Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703–712.
Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA 2002;287;628–640.
O’Connell JB. The economic burden of heart failure. Clin Cardiol 2000;23: III6–III10.
McAlister FA, Stewart S, Ferrua S, McMurray JJJV. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. J Am Coll Cardiol 2004;44:810–819.
Tsuchihashi M, et al. Medical and socioenvironmental predictors of hospital readmission in patients with congestive heart failure. Am Heart J 2001;142:703.
Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190–1195.
Berg GD, Wadhwa S, Johnson AE. A matched-cohort study of health services utilization and financial outcomes for a heart failure disease-management program in elderly patients. J Am Geriatr Soc 2004;52:1655–1661.
Halvorson GC, Isham GJ. Epidemic of Care: A Call for Safer, Better, and More Accountable Health Care. San Francisco: Jossey-Bass, 2003.
Fonarow GC. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF. Rev Cardiovasc Med 2004;5(Suppl 1):S45–S54.
Galbreath AD, Krasuski RA, Smith B, Stajduhar KC, Kwan MD, Ellis R, Freeman GL. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 2004;110:1–9.
Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;261:884–888.
McKee PA, Castelli WP, et al. The natural history of congestive heart failure. The Framingham Study. N Engl J Med 1971;285:1441–1447.
Maisel AS, et al. Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161–167.
Kitzman DW, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002;288:2144–2150.
Vasan RS, et al. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997;336:1350–1355.
Devereux RB, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004;292:2350–2356.
Okin PM, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 2004;292;2343–2349.
Hernandez AF, O’Connor CM. Lessons from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 2003;42:709–711.
Mirvis DM. Electrocardiography: A Physiologic Approach. St. Louis: Mosby, 1993.
de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Published online April 23, 2003, at http://image.thelancet. com/extras/02art2325web.pdf.
Kannel WB, D’Agostino RB, Silbershatz H, et al. Profile for estimating risk of heart failure. Arch Intern Med 1999;159:1197.
Hunt SA, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Heart Lung Transplant 2002;21: 189–203.
Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 1992;124:1017–1025.
Demers C, et al. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J 2001;142:698–703.
ACC/AHA, and Physician Consortium for Performance Improvement Heart Failure Core Physician Performance Measurement Set: Prospective Data Collection Flowsheet, available at www.ama-assn.org/go/quality.
Riegel B, et al. Psychometric testing of the self-care of heart failure index. J Cardiac Failure 2004;10:350–360.
Chriss PM, Sheposh J, Riegel B. Predictors of successful heart failure self-care maintenance in the first three months after hospitalization. Heart Lung 2004;33:345–353.
Murray MD, et al. Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure. Am J Geriatr Pharmacother 2004;2:53–65.
Ross SE, Moore LA, Earnest MA, Wittevrongel L, Lin CT. Providing a Webbased online medical record with electronic communication capabilities to patients with congestive heart failure: randomized trial. J Med Internet Res 2004;6:e14.
Riegel B, Carlson B. Is individual peer support a promising intervention for persons with heart failure? J Cardiovasc Nurs 2004;19:174–183.
Feldman PH, et al. A randomized intervention to improve heart failure outcomes in community-based home health care. Home Health Care Serv Q 2004;23:1–23.
Holman H, Lorig K. Patient self-management: a key to effectiveness and efficiency in care of chronic disease. Public Health Rep 2004;119:239–243.
Frantz AK. Breaking down the barriers to heart failure patient self-care. Home Health Nurse 2004;22:109–115.
DeGeest S, et al. Complexity in caring for an ageing heart failure population: concomitant chronic conditions and age related impairments. Eur J Cardiovasc Nurse 2004:3:263–270.
Jaarmsa T, Halfens R, Tan F, Abu-Saad HH, Dracup K, Diederiks J. Self-care and quality of life in patients with advanced heart failure: the effect of a supportive educational intervention. Heart Lung 2000;29:319–330.
Miranda MB, et al. An evidence-based approach to improving care of patients with heart failure across the continuum. J Nurs Care Qual 2002;17: 1–14.
DeWalt DA, et al. Development and pilot testing of a disease management program for low literacy patients with heart failure. Patient Educ Counseling 2004;55:78–86.
Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA 2003;288:2469–2475.
Hambrecht R, et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial. JAMA 2000;283:3095–3101.
Corvera-Tindel T, Doering LV, Gomez T, Dracup K. Predictors of noncompliance to exercise training in heart failure. J Cardiovasc Nurs 2004;19:269–277.
Asakuma S, Ohyani M, Iwasaki T. Use of pedometer counts in heart failure. Congest Heart Fail 2000;6:250–255.
Murberg TA, Furze G. Depressive symptoms and mortality in patients with congestive heart failure: a six-year follow-up study. Med Sci Monit 2004;10: CR643–CR648.
Poole-Wilson PA. ACE inhibitors and ARBs in chronic heart failure: the established, the expected, and the pragmatic. Med Clin North Am 2003;87:373–389.
Cruden NL, Newby DE. Angiotensin antagonism in patients with heart failure: ACE inhibitors, angiotensin receptor antagonists or both? Am J Cardiovasc Drugs 2004;4:345–353.
Cleland JGF. Beta-blockers for heart failure: why, which, when, and where. Med Clin North Am 2003;87:339–371.
Stevenson LW. Beta-blockers for stable heart failure. N Engl J Med 2002;346:1346–1347.
Rajagopalan S, Pitt B. Aldosterone as a target in congestive heart failure. Med Clin North Am 2003;87:441–457.
Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543–551.
Jones RC, Francis GS, Lauer MS. Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol 2004;44:1025–1029.
Dec GW. Digoxin remains useful in the management of chronic heart failure. Med Clin North Am 2003;87:317–337.
Taylor AL, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004;351:2049–2057.
Piette, et al. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med 2004;164:1749–1755.
Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol 2003;41:56–61.
Fonarow CG, Gheorghiade M, Abraham WT. Importance of in-hospital initiation of evidence-based medical therapies for heart failure—a review. Am J Cardiol 2004;94:1155–1160.
Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure. A meta-analysis. JAMA 2004;291:1358–1367.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lewis, W., Nuovo, J. (2007). Heart Failure. In: Chronic Disease Management. Springer, New York, NY. https://doi.org/10.1007/978-0-387-49369-5_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-49369-5_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-32927-7
Online ISBN: 978-0-387-49369-5
eBook Packages: MedicineMedicine (R0)